Insider · CIK 0001636168

Nicholson, C. David

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001636168

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	ATNMActinium Pharmaceuticals, Inc.A Award	Director	AAward	+62.8K sh	—	—	63,300
2026-09-02	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+94.2K sh	—	—	94,200
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.5K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.5K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,450
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,333 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,333 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.4K sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−72.2K sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−70.3K sh	—	—	0
2024-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,520
2023-12-28	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+70.3K sh	—	—	70,311
2023-11-03	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2022-07-01	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+72.2K sh	—	—	72,156
2021-09-01	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,351
2020-08-12	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2019-07-12	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Director	AAward	+250K sh	$0.23	+$58K	250,000
2018-07-13	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Director	AAward	+75K sh	$0.78	+$58.7K	75,000
2017-03-14	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Director	AAward	+75K sh	$1.39	+$104K	75,000
2016-04-15	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Director	AAward	+75K sh	$1.99	+$149K	75,000
2016-04-14	ATNMActinium Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+5,000 sh	$2.00	+$10K	15,000

Recent filings

Accepted (ET)
Sep 44
Nicholson, C. David0001213900-26-097745
SEC(opens sec.gov)
Dec 104
Nicholson, C. David0001636168-25-000003
SEC(opens sec.gov)
Jun 204
Nicholson, C. David0001415889-25-017846
SEC(opens sec.gov)
Apr 24
Nicholson, C. David0001213900-25-028228
SEC(opens sec.gov)
Jun 204
Nicholson, C. David0001415889-24-017680
SEC(opens sec.gov)
Dec 294
Nicholson, C. David0001213900-23-100091
SEC(opens sec.gov)
Nov 64
Nicholson, C. David0001209191-23-054582
SEC(opens sec.gov)
Jul 14
Nicholson, C. David0001213900-22-036875
SEC(opens sec.gov)
Sep 34
Nicholson, C. David0001213900-21-046679
SEC(opens sec.gov)
Aug 144
Nicholson, C. David0001213900-20-022313
SEC(opens sec.gov)

Companies

Address

C/O ACTINIUM PHARMACEUTICALS, INC. 100 PARK AVE., 23RD FLOOR

NEW YORK, NY, 10017